Topic description and stories

Digital image of a molecule

Accelerating how new drugs are made with machine learning

15 Jan 2024

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could...

Read more
Scientist looking down microscope

Cambridge partners with AstraZeneca and Medical Research Council on new world-class functional genomics laboratory

27 Nov 2023

The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by...

Read more
Alzheimers disease. Computer illustration of amyloid plaques amongst neurons.

AI-driven techniques reveal new targets for drug discovery

27 Sep 2023

Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.

Read more

Scanning electron microscopy of highly crystalline metal-organic framework nanoparticles

Cambridge spin-out receives £2.2 million to help improve cancer treatments

01 Mar 2023

Vector Bioscience has received a £2.2 million investment to help it take forward its drug delivery platform designed to make RNA cancer therapies...

Read more
SemaCyte cell assaying platform

Drug-screening spin-out secures new funding

23 Feb 2022

A University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies...

Read more

Training a new breed of clinical triallist

03 Feb 2022

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of...

Read more

Woman in grey shirt

‘Transformational’ approach to machine learning could accelerate search for new disease treatments

29 Nov 2021

Researchers have developed a new approach to machine learning that ‘learns how to learn’ and out-performs current machine learning methods for drug...

Read more
Graphical representation of COVID-19 and network analysis

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 Jun 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...

Read more
Neurons

Heal thyself

24 May 2021

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore...

Read more

Human cells with acute myelocytic leukemia, shown with an esterase stain at 400x

Scientists develop new class of cancer drug with potential to treat leukaemia

26 Apr 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published...

Read more

Cell ‘membrane on a chip’ could speed up screening of drug candidates for COVID-19

06 Jul 2020

Researchers have developed a human cell ‘membrane on a chip’ that allows continuous monitoring of how drugs and infectious agents interact with our...

Read more

Strategic partner: AstraZeneca

11 Nov 2019

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge University for more than two decades. What are the...

Read more

Pages